Invention Grant
- Patent Title: Methods and compositions for inducing hematopoietic cell differentiation
-
Application No.: US15773519Application Date: 2016-07-26
-
Publication No.: US10858628B2Publication Date: 2020-12-08
- Inventor: Bahram Valamehr , Raedun Clarke , Ryan Bjordahl
- Applicant: Fate Therapeutics, Inc.
- Applicant Address: US CA San Diego
- Assignee: Fate Therapeutics, Inc.
- Current Assignee: Fate Therapeutics, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- International Application: PCT/US2016/044122 WO 20160726
- International Announcement: WO2017/078807 WO 20170511
- Main IPC: C12N5/0789
- IPC: C12N5/0789 ; A61K35/28 ; G01N33/50 ; A61K39/00 ; A61K35/545

Abstract:
The invention provides culture platforms, cell media, and methods of differentiating pluripotent cells into hematopoietic cells. The invention further provides pluripotent stem cell-derived hematopoietic cells generated using the culture platforms and methods disclosed herein, which enable feed-free, monolayer culturing and in the absence of EB formation. Specifically, pluripotent stem cell-derived hematopoietic cell of this invention include, and not limited to, iHSC, definitive hemogenic endothelium, hematopoietic multipotent progenitors, T cell progenitors, NK cell progenitors, T cells, NK cells, NKT cells and B cells.
Public/Granted literature
- US20180320137A1 METHODS AND COMPOSITIONS FOR INDUCING HEMATOPOIETIC CELL DIFFERENTIATION Public/Granted day:2018-11-08
Information query